GetTopicDetailResponse(id=6b711283e536, topicName=中藥活性成分HSC, introduction=, content=慢性阻塞性肺疾病 中藥活性成分HSC, image=null, comments=0, allHits=160, url=null, type=1, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Sat Jul 05 22:30:18 CST 2025, time=2025-07-05, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=506248, tagList=[TagDto(tagId=506248, tagName=中藥活性成分HSC)], ipAttribution=上海, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2272222, encodeId=0e8622e22229f, content=<a href='/topic/show?id=344353e0291' target=_blank style='color:#2F92EE;'>#慢性阻塞性肺疾病#</a> <a href='/topic/show?id=6b711283e536' target=_blank style='color:#2F92EE;'>#中藥活性成分HSC#</a>, objectTitle=Chinese Medicine：中藥活性成分HSC阻斷 TLR4/NF-κB/MAPK 通路為慢性阻塞性肺疾病治療提供雙重靶點策略, objectType=article, longId=885544, objectId=3f2f88554410, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20250107/1736227021716_8538692.png, objectUrl=/article/show_article.do?id=3f2f88554410, replyNumber=0, likeNumber=31, createdTime=2025-07-05, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=3f2f88554410, moduleTitle=Chinese Medicine：中藥活性成分HSC阻斷 TLR4/NF-κB/MAPK 通路為慢性阻塞性肺疾病治療提供雙重靶點策略, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=3f2f88554410)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2025-07-05發(fā)表于上海
